Taysha Gene Therapies, Inc. (TSHA)

Taysha Gene Therapies Statistics

Total Valuation

TSHA has a market cap or net worth of $313.56 million. The enterprise value is $199.12 million.

Market Cap	313.56M
Enterprise Value	199.12M

Important Dates

The next estimated earnings date is Tuesday, November 12, 2024, after market close.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

TSHA has 204.94 million shares outstanding. The number of shares has increased by 256.03% in one year.

Shares Outstanding	204.94M
Shares Change (YoY)	+256.03%
Shares Change (QoQ)	+0.68%
Owned by Insiders (%)	13.21%
Owned by Institutions (%)	56.05%
Float	122.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	23.80
Forward PS	34.27
PB Ratio	2.83
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	15.47
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.22, with a Debt / Equity ratio of 0.54.

Current Ratio	5.22
Quick Ratio	5.05
Debt / Equity	0.54
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-34.40

Financial Efficiency

Return on equity (ROE) is -318.69% and return on invested capital (ROIC) is -50.56%.

Return on Equity (ROE)	-318.69%
Return on Assets (ROA)	-34.17%
Return on Capital (ROIC)	-50.56%
Revenue Per Employee	$247,558
Profits Per Employee	-$2.20M
Employee Count	52
Asset Turnover	0.09
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -34.62% in the last 52 weeks. The beta is 0.41, so TSHA's price volatility has been lower than the market average.

Beta (5Y)	0.41
52-Week Price Change	-34.62%
50-Day Moving Average	2.06
200-Day Moving Average	2.39
Relative Strength Index (RSI)	19.85
Average Volume (20 Days)	1,800,692

Short Selling Information

The latest short interest is 20.70 million, so 10.10% of the outstanding shares have been sold short.

Short Interest	20.70M
Short Previous Month	20.64M
Short % of Shares Out	10.10%
Short % of Float	16.93%
Short Ratio (days to cover)	10.85

Income Statement

In the last 12 months, TSHA had revenue of $12.87 million and -$114.34 million in losses. Loss per share was -$0.57.

Revenue	12.87M
Gross Profit	12.87M
Operating Income	-77.06M
Pretax Income	-118.01M
Net Income	-114.34M
EBITDA	-75.72M
EBIT	-77.06M
Loss Per Share	-$0.57

Balance Sheet

The company has $172.74 million in cash and $58.30 million in debt, giving a net cash position of $114.44 million or $0.56 per share.

Cash & Cash Equivalents	172.74M
Total Debt	58.30M
Net Cash	114.44M
Net Cash Per Share	$0.56
Equity (Book Value)	108.87M
Book Value Per Share	0.54
Working Capital	144.29M

Cash Flow

In the last 12 months, operating cash flow was -$75.37 million and capital expenditures -$358,000, giving a free cash flow of -$75.73 million.

Operating Cash Flow	-75.37M
Capital Expenditures	-358,000
Free Cash Flow	-75.73M
FCF Per Share	-$0.37

Margins

Gross Margin	100.00%
Operating Margin	-598.62%
Pretax Margin	-888.18%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-513.85%

Dividends & Yields

TSHA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-256.03%
Shareholder Yield	-256.03%
Earnings Yield	-36.46%
FCF Yield	-24.15%

Analyst Forecast

The average price target for TSHA is $6.38, which is 316.99% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.38
Price Target Difference	316.99%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	58.83%
EPS Growth Forecast (5Y)	-20.45%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TSHA has an Altman Z-Score of -1.62 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.62
Piotroski F-Score	4